Regenecyte is under clinical development by StemCyte and currently in Pre-Registration for Unspecified Hematological Disorders. According to GlobalData, Pre-Registration drugs for Unspecified ...
Sanofi has won FDA approval for its sutimlimab for cold agglutinin disease (CAD) at the second time of asking, becoming the first approved therapy for the rare blood disorder in the US.
In winters, ginger is used a lot in everyone's homes, from morning tea to food. If you avoid eating ginger, then know that the consumption of ginger is considered very beneficial in these 5 diseases, ...
A world leading UK Biobank study of half a million Brits could unlock the mysteries of ‘proteomics’ to prevent and cure diseases from cancer to Alzheimer’s and multiple sclerosis ...